MEDI holdings
Harbor Health Care ETF
Positions
44 stored of 44 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 532457108 | 20.784% | $8.6M | Equity (common) | Corporate | United States | USD |
| 2 | Ascendis Pharma A/S | DK0060615755 | Not reported | 13.610% | $5.6M | Equity (common) | Corporate | Denmark | USD |
| 3 | Gilead Sciences Inc | US3755581036 | 375558103 | 5.098% | $2.1M | Equity (common) | Corporate | United States | USD |
| 4 | Rhythm Pharmaceuticals Inc | US76243J1051 | 76243J105 | 4.017% | $1.7M | Equity (common) | Corporate | United States | USD |
| 5 | AbbVie Inc | US00287Y1091 | 00287Y109 | 3.093% | $1.3M | Equity (common) | Corporate | United States | USD |
| 6 | Intuitive Surgical Inc | US46120E6023 | 46120E602 | 2.830% | $1.2M | Equity (common) | Corporate | United States | USD |
| 7 | Cencora Inc | US03073E1055 | 03073E105 | 2.746% | $1.1M | Equity (common) | Corporate | United States | USD |
| 8 | Revolution Medicines Inc | US76155X1000 | 76155X100 | 2.541% | $1.0M | Equity (common) | Corporate | United States | USD |
| 9 | Insmed Inc | US4576693075 | 457669307 | 2.515% | $1.0M | Equity (common) | Corporate | United States | USD |
| 10 | Merck & Co Inc | US58933Y1055 | 58933Y105 | 2.467% | $1.0M | Equity (common) | Corporate | United States | USD |
| 11 | Boston Scientific Corp | US1011371077 | 101137107 | 2.400% | $989K | Equity (common) | Corporate | United States | USD |
| 12 | Natera Inc | US6323071042 | 632307104 | 2.258% | $930K | Equity (common) | Corporate | United States | USD |
| 13 | Abivax SA | US00370M1036 | 00370M103 | 2.164% | $892K | Equity (common) | Corporate | France | USD |
| 14 | Insulet Corp | US45784P1012 | 45784P101 | 2.097% | $864K | Equity (common) | Corporate | United States | USD |
| 15 | Argenx SE | US04016X1019 | 04016X101 | 2.074% | $855K | Equity (common) | Corporate | Netherlands | USD |
| 16 | Vaxcyte Inc | US92243G1085 | 92243G108 | 2.060% | $849K | Equity (common) | Corporate | United States | USD |
| 17 | McKesson Corp | US58155Q1031 | 58155Q103 | 2.024% | $834K | Equity (common) | Corporate | United States | USD |
| 18 | Legend Biotech Corp | US52490G1022 | 52490G102 | 1.909% | $787K | Equity (common) | Corporate | Cayman Islands | USD |
| 19 | Danaher Corp | US2358511028 | 235851102 | 1.726% | $711K | Equity (common) | Corporate | United States | USD |
| 20 | Guardant Health Inc | US40131M1099 | 40131M109 | 1.543% | $636K | Equity (common) | Corporate | United States | USD |
| 21 | Novo Nordisk A/S | US6701002056 | 670100205 | 1.460% | $602K | Equity (common) | Corporate | Denmark | USD |
| 22 | IDEXX Laboratories Inc | US45168D1046 | 45168D104 | 1.403% | $578K | Equity (common) | Corporate | United States | USD |
| 23 | UnitedHealth Group Inc | US91324P1021 | 91324P102 | 1.390% | $573K | Equity (common) | Corporate | United States | USD |
| 24 | PTC Therapeutics Inc | US69366J2006 | 69366J200 | 1.306% | $538K | Equity (common) | Corporate | United States | USD |
| 25 | Vertex Pharmaceuticals Inc | US92532F1003 | 92532F100 | 1.219% | $502K | Equity (common) | Corporate | United States | USD |
| 26 | Alnylam Pharmaceuticals Inc | US02043Q1076 | 02043Q107 | 1.212% | $499K | Equity (common) | Corporate | United States | USD |
| 27 | Thermo Fisher Scientific Inc | US8835561023 | 883556102 | 1.164% | $480K | Equity (common) | Corporate | United States | USD |
| 28 | Adaptive Biotechnologies Corp | US00650F1093 | 00650F109 | 0.978% | $403K | Equity (common) | Corporate | United States | USD |
| 29 | Madrigal Pharmaceuticals Inc | US5588681057 | 558868105 | 0.927% | $382K | Equity (common) | Corporate | United States | USD |
| 30 | Praxis Precision Medicines Inc | US74006W2070 | 74006W207 | 0.912% | $376K | Equity (common) | Corporate | United States | USD |
| 31 | Dexcom Inc | US2521311074 | 252131107 | 0.806% | $332K | Equity (common) | Corporate | United States | USD |
| 32 | RadNet Inc | US7504911022 | 750491102 | 0.796% | $328K | Equity (common) | Corporate | United States | USD |
| 33 | Penumbra Inc | US70975L1070 | 70975L107 | 0.769% | $317K | Equity (common) | Corporate | United States | USD |
| 34 | Relay Therapeutics Inc | US75943R1023 | 75943R102 | 0.642% | $264K | Equity (common) | Corporate | United States | USD |
| 35 | Oruka Therapeutics Inc | US6876041087 | 687604108 | 0.596% | $246K | Equity (common) | Corporate | United States | USD |
| 36 | IRhythm Holdings Inc | US4500561067 | 450056106 | 0.576% | $237K | Equity (common) | Corporate | United States | USD |
| 37 | Viatris Inc | US92556V1061 | 92556V106 | 0.572% | $236K | Equity (common) | Corporate | United States | USD |
| 38 | Newamsterdam Pharma Co NV | NL00150012L7 | Not reported | 0.516% | $213K | Equity (common) | Corporate | Netherlands | USD |
| 39 | Xenon Pharmaceuticals Inc | CA98420N1050 | 98420N105 | 0.511% | $211K | Equity (common) | Corporate | Canada | USD |
| 40 | Indivior Pharmaceuticals Inc | US45579U1097 | 45579U109 | 0.499% | $206K | Equity (common) | Corporate | United States | USD |
| 41 | Axsome Therapeutics Inc | US05464T1043 | 05464T104 | 0.491% | $203K | Equity (common) | Corporate | United States | USD |
| 42 | Inventiva SACA | US46124U1079 | 46124U107 | 0.370% | $152K | Equity (common) | Corporate | France | USD |
| 43 | Sophia Genetics SA | CH1125843347 | Not reported | 0.334% | $138K | Equity (common) | Corporate | Switzerland | USD |
| 44 | Ionis Pharmaceuticals Inc | US4622221004 | 462222100 | 0.205% | $84K | Equity (common) | Corporate | United States | USD |